Stock Code
688016.SH
Stock Code
688016.SH
Technology Innovation, People Centric
Adhering to the mission of providing trustworthy and universal access to state-of-the-art solutions of prolonging and reshaping all lives, Endovastec™ is committed to building a leading enterprise of emerging technologies in great vessel surgery and peripheral vascular medicine.
Products
Endovastec™ focuses on the research and development (R&D), manufacturing, sales and services of aortic, peripheral vascular and tumor intervention devices,and our main products are thoracic and abdominal aortic stent grafts, stent grafts in surgical operation, peripheral vascular stents, drug-coated balloon dilatation catheters, balloon dilatation catheters, vena cava filters and snare retrieval kits etc.
News
.png)
Endovastec™’s Cratos™ Completes First Commercial Use in Hungary
Endovastec™ recently announced the first commercial use of its Cratos™ Thoracic Branch Stent Graft System (Cratos™) in Hungary. The procedure was performed by Dr. Gabor Kasza, Dr. Gabor Fazekas, and their team at University of Pecs Medical School in Pecs, Hungary.
12 Sept 2025
.png)
Endovastec™’s Minos™ Completes First Commercial Implantation in Kazakhstan
Endovastec™ announced the first commercial implantation of its Minos™ Abdominal Aortic Stent Graft and Delivery System (Minos™) in Kazakhstan. This marks the latest addition to the company’s product portfolio in this region, following of its Castor™ Branched Aortic Stent Graft System.
16 Jul 2025
.png)
Endovastec™ Completes the First Batch of Commercial Uses of Next-Generation Cratos™
Recently, the next-generation Cratos™ Branched Aortic Stent Graft System (Cratos™), developed by Endovastec™, was successfully used in two post-market clinical implantations at Zhongshan Hospital Fudan University, performed by Professors Weiguo Fu and Lixin Wang, and their team. These procedures mark a key milestone in the commercial clinical application of Cratos™ in China, following its regulatory approval in March 2025.
27 Jun 2025
About us
News
Products
Investor Relations
Telephone:(86) (21) 38139300
Address:Building #1,3399 Kangxin Rd., SIMZ Century Medicine Park, Shanghai201318,P.R. China
Fax:(86) (21) 33750026
©Copyright 2002-2025, Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd.
Internet Drug Information Service Qualification Certificate No.: (Hu) - Non-operating -2024-0188
Website record/ license No.：沪ICP备14048493号-1 
HGWA Bei No.31011502014536
The registered trademarks of “微创", "MicroPort" and"
" are registered trademarks of Shanghai MicroPort Medical (Group) Co., Ltd., they have been authorized to be used by Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd., and no other party shall use such trademarks without prior written permission thereof.
